Credit: Getty Images. The recall was initiated due to product stability testing results that did not meet specifications for iron content. Allergan has expanded its December 2017 voluntary recall of ...

PRINCETON, N.J., September 24, 2025--(BUSINESS WIRE)--Sandoz (SIX: SDZ; OTCQX: SDZNY), the global leader in affordable medicines, today announced the US launch of its generic iron sucrose injection ...

The FDA approved ferric derisomaltose injection for the treatment of iron deficiency anemia in adults who had an intolerance or unsatisfactory response to oral iron or who have ...

Monoferric will be supplied in 100mg/mL, 500mg/5mL, and 1000mg/10mL single-dose vials for intravenous infusion after dilution. The Food and Drug Administration (FDA) has approved Monoferric (ferric ...

AN iron-dextran combination of low molecular weight§ has proved to be effective in correcting the anemia of iron deficiency. Hagedorn 1 reported that over 400 injections had been given at the Mayo ...

Approval Granted with Competitive Generic Therapy Eligibility for 100mg/5mL and 200mg/10mL Strengths; Provides Eligibility for 180 Days of Exclusivity Viatris Chief R&D Officer Philippe Martin said, ...

Viatris Inc (NASDAQ:VTRS) saw its stock increase by 2.6% after the U.S. Food and Drug Administration approved its Iron Sucrose Injection, USP, marking the first generic alternative to Venofer® ...

Expands access to much-needed iron therapy for millions of US patients Builds Sandoz portfolio of high-quality injectable iron therapies and sets stage for future launches Strengthens US supply of ...